# Arxis, Inc.: overview ARXS · Nasdaq · CIK 2093536 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/arxs.md) · [Financials](/companies/arxs/financials.md) · [Filings](/companies/arxs/filings.md) · [Insiders](/companies/arxs/insiders.md) Latest reported revenue: [$564.0m](/filings/0001193125-26-437000.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-437000). ## Last eight quarters | Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [380](/filings/0001193125-26-243043.md) | [400](/filings/0001193125-26-325027.md) | [415](/filings/0001193125-26-437000.md) | [459](/filings/0001193125-26-243043.md) | [501](/filings/0001193125-26-325027.md) | [564](/filings/0001193125-26-437000.md) | | Gross margin | % | [42.9%](/filings/0001193125-26-243043.md) | [49.3%](/filings/0001193125-26-325027.md) | [49.2%](/filings/0001193125-26-437000.md) | [51.2%](/filings/0001193125-26-243043.md) | [52.4%](/filings/0001193125-26-325027.md) | [54.3%](/filings/0001193125-26-437000.md) | | Operating margin | % | [15.8%](/filings/0001193125-26-243043.md) | [20.7%](/filings/0001193125-26-325027.md) | [22.2%](/filings/0001193125-26-437000.md) | [24.1%](/filings/0001193125-26-243043.md) | [6.5%](/filings/0001193125-26-325027.md) | [23.7%](/filings/0001193125-26-437000.md) | | Net margin | % | [(1.1%)](/filings/0001193125-26-437000.md) | [(7.3%)](/filings/0001193125-26-437000.md) | [(2.4%)](/filings/0001193125-26-437000.md) | [11.6%](/filings/0001193125-26-437000.md) | [(1.0%)](/filings/0001193125-26-437000.md) | [14.8%](/filings/0001193125-26-437000.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.01)](/filings/0001193125-26-325027.md) | [0.20](/filings/0001193125-26-437000.md) | | Free cash flow | $m | [12.0](/filings/0001193125-26-243043.md) | [35.2 d](/filings/0001193125-26-325027.md) | [68.8 d](/filings/0001193125-26-437000.md) | [24.8](/filings/0001193125-26-243043.md) | [127 d](/filings/0001193125-26-325027.md) | [150 d](/filings/0001193125-26-437000.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years Not reported. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/arxs/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $208.4m | 4,516,959 | | Not compared | | [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $166.3m | 3,603,927 | | New +3,603,927 | | [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $165.9m | 3,595,083 | | New +3,595,083 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $122.6m | 2,656,793 | | New +2,656,793 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $101.4m | 2,196,658 | | New +2,196,658 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $86.0m | 1,862,985 | | New +1,862,985 | | [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $84.6m | 1,833,104 | | New +1,833,104 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $74.2m | 1,608,151 | | New +1,608,151 | | [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $72.8m | 1,536,450 | | New +1,536,450 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $69.2m | 1,498,866 | | New +1,498,866 | ## Recent filings [All 50 filings](/companies/arxs/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 07:50 ET | [8-K/A](/filings/0001193125-26-437030.md) | 9.01 Financial statements and exhibits | 0001193125-26-437030 | | 2026-10-29 | 07:30 ET | [10-Q](/filings/0001193125-26-437000.md) | Quarterly report, period 2026-09-30 | 0001193125-26-437000 | | 2026-10-28 | 16:15 ET | [8-K](/filings/0001193125-26-436169.md) | 9.01 Financial statements and exhibits | 0001193125-26-436169 | | 2026-10-13 | 07:46 ET | [S-1](/filings/0001193125-26-419718.md) | Registration statement | 0001193125-26-419718 | | 2026-08-18 | 08:30 ET | [8-K](/filings/0001193125-26-354774.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-354774 | | 2026-07-30 | 08:30 ET | [10-Q](/filings/0001193125-26-325027.md) | Quarterly report, period 2026-06-30 | 0001193125-26-325027 | | 2026-07-29 | 16:15 ET | [8-K](/filings/0001193125-26-323755.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323755 | | 2026-06-02 | 07:00 ET | [8-K](/filings/0001193125-26-252459.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-252459 | | 2026-05-28 | 11:56 ET | [8-K](/filings/0001193125-26-243574.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-243574 | | 2026-05-28 | 08:14 ET | [10-Q](/filings/0001193125-26-243043.md) | Quarterly report, period 2026-03-31 | 0001193125-26-243043 | ## Latest annual report No annual report is in coverage. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/b7336886-8792-412f-b375-bb70f0c06aa2) ## About the filer - CIK: 2093536 - Tickers: ARXS - Exchange: Nasdaq - SIC code: 3728 Aircraft Parts & Auxiliary Equipment, NEC - State of incorporation: DE - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 07:56 ET. No prices; not investment advice.